Live feed
Filing
SC 13D
SC 13D0000903423-17-000691·GSK plc
Schedule 13D ownership disclosure
Spero Therapeutics Inc
Security class unavailable · CUSIP: 84833T103
Event date: 2017-11-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,854,006
- Percent of class
- 13.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-17-000691
- Form type
- SC 13D
- Filer
- GSK plc
- CIK
- CIK 1131399
- Filed
- Nov 16, 2017
- Reporting period
- Nov 06, 2017
- Description
- Schedule 13D beneficial ownership